BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7664937)

  • 1. Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association.
    Hsieh DP; Atkinson DN
    Food Addit Contam; 1995; 12(3):421-4. PubMed ID: 7664937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
    Fujimoto Y; Hampton LL; Luo LD; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1992 Feb; 52(4):1044-6. PubMed ID: 1310637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
    Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins.
    Gerbes AL; Caselmann WH
    J Hepatol; 1993 Sep; 19(2):312-5. PubMed ID: 8301066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
    Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
    Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation at codon 249 of p53 gene in a human hepatoblastoma.
    Kar S; Jaffe R; Carr BI
    Hepatology; 1993 Sep; 18(3):566-9. PubMed ID: 8395458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells.
    Schleger C; Becker R; Oesch F; Steinberg P
    Hepatology; 1999 Mar; 29(3):834-8. PubMed ID: 10051487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7.
    Uwaifo O
    Afr J Med Med Sci; 1999; 28(1-2):71-5. PubMed ID: 12953991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutation pattern in rat liver tumors induced by vinyl chloride.
    Barbin A; Froment O; Boivin S; Marion MJ; Belpoggi F; Maltoni C; Montesano R
    Cancer Res; 1997 May; 57(9):1695-8. PubMed ID: 9135010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.